Gilead ends a Phase 2/3 trial of long-acting HIV pillsnews2026-04-01T23:18:50+00:00April 1st, 2026|Endpoints News|
AFPM ’26: Steep price increase proposals, as well as soaring spot prices, emerge for US PG due to multiple supply concernsnews2026-04-01T22:06:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
PODCAST: BD global market tightness continues heading into April amid Middle East conflictnews2026-04-01T21:39:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
US court ruling against a challenge to FMC final rule benefits American shippers – ACDnews2026-04-01T21:37:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
US gasoline supplies decline as refinery run rates fallnews2026-04-01T21:27:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
Chile’s economy contracts in February as manufacturing weighs on activitynews2026-04-01T21:25:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
Colombia manufacturing expands then eases some in Marchnews2026-04-01T21:20:00+00:00April 1st, 2026|Independent Commodity Intelligence Services (ICIS)|
Noom plans push into peptides beyond weight loss drugsnews2026-04-01T20:47:39+00:00April 1st, 2026|Endpoints News|
F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayonews2026-04-01T20:44:40+00:00April 1st, 2026|The New York Times|
